Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
China actively optimizes COVID-19 response measures to better prepare for challenges
2022-12-26 14:32
CGTN: 'New Approaches': How China stepped up its COVID-19 treatments
2022-12-21 18:51
CGTN: New Approaches : How China pushes COVID-19 vaccine R&D and inoculation
2022-12-20 22:53
PHASE II/III CLINICAL TRIAL OF SIMCERE'S 3CL-TARGETING ANTI-SARS-COV-2 DRUG CANDIDATE COMPLETE ALL PATIENTS ENROLLMENT
2022-12-20 19:21
CGTN: New Approaches: Why China is easing its COVID-19 curbs now
2022-12-20 10:59
Clinical Trial Approval For The Company's Novel Adjuvanted Recombinant Shingles Vaccine REC610 In The Philippines
2022-12-19 13:53
Bioved Pharmaceuticals, Inc. announces the results of its Phase III Randomized Clinical Trial in Moderate Covid-19 with Artovid-20®, a natural plant-based oral product
2022-12-16 01:30
Novavax Announces Proposed Offering of $125 Million of Convertible Senior Notes
2022-12-15 23:43
International Collaboration to Improve Cancer Care in Sub-Saharan Africa Focuses on Resources for Children's Cancers
2022-12-15 14:07
Stemirna receives Emergency Use Authorization from Laos for its proprietary mRNA vaccine
2022-12-15 12:27
CGTN: How China strengthens vaccine cooperation to battle COVID-19
2022-12-15 09:16
Novavax Announces Proposed $125 Million Public Offering of Common Stock
2022-12-15 05:39
E-Home Household Services Holdings Limited's subsidiary Zhong Run Launches Cloud Pharmacy Service to Address New Situation of Epidemic Prevention and Control
2022-12-14 21:30
Superior Results Of The Comparative Study Of The Company's Recombinant Two-Component COVID-19 Vaccine ReCOV As Compared To International Mainstream mRNA Vaccine
2022-12-14 15:17
CGTN: 'New Approaches': Hospitals gear up to prioritize COVID-19 patients
2022-12-14 12:36
Fosun International Receives "ESG Leading Enterprise Award" and "ESG Leading Social Initiative Award" from Bloomberg Businessweek/Chinese Edition
2022-12-14 11:09
CGTN: The Chinese are sharing their COVID experiences as policy optimized
2022-12-13 12:49
Epidemic: Modified approach ensures maximum benefit
2022-12-13 11:42
CGTN: Infrastructure, vaccines and space: China-Arab sci-tech cooperation
2022-12-12 15:39
China further optimizes COVID-19 response with new measures
2022-12-12 11:38
1
7
8
9
10
11
91